Kilpatrick Townsend & Stockton and Robins Kaplan filed a lawsuit Thursday in Washington Western District Court on behalf of Premera Blue Cross. The complaint accuses Omaha, Nebraska-based GS Labs of scheming against patients and insurers to increase its profits by convincing patients that they need to take all three COVID-19 tests that GS Labs offers. The suit also claims that GS Labs misrepresented its “cash prices” to maximize insurance reimbursement. Counsel have not yet appeared for the defendant. The case is 2:21-cv-01399, Premera Blue Cross v. GS Labs, LLC.
This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Not a Bloomberg Law Subscriber?
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]